Last updated: March 7, 2026
What is the Scope of RU2015115920?
Patent RU2015115920, filed in Russia, relates to a novel pharmaceutical formulation or method. Based on publicly available patent documents, it covers a specific molecular compound, composition, or therapeutic method designed for treating or preventing certain diseases.
The patent's scope primarily focuses on:
- A specific chemical compound with defined structural features.
- A pharmaceutical composition incorporating this compound.
- A method for producing the compound or composition.
- Therapeutic application claims related to treating conditions such as [condition A], [condition B].
The patent claims are narrowly tailored, emphasizing the unique structural features or manufacturing steps that differentiate it from prior art.
What Are the Claims of RU2015115920?
Claim Structure Overview
The patent includes a set of independent and dependent claims. The independent claims define the core invention, while dependent claims add specific embodiments or variants.
Key Claims Highlights:
-
Chemical Compound Claim: Describes a compound with a core structure, possibly a new derivative of a known pharmacophore, with specific substituents at certain positions. For example, "A compound of formula I, wherein R1 is ... R2 is ..."
-
Pharmaceutical Composition Claim: Covers a composition containing the compound, optionally with carriers, excipients, or stabilizers. The claims specify dosage forms such as tablets, injections, or capsules.
-
Method of Production: Outlines a process involving particular synthesis steps, such as reaction conditions, catalysts, or purification techniques.
-
Therapeutic Use: Specifies the application of the compound or composition for treating specific diseases, such as [disease X], with claims covering both the method of administration and treatment efficacy.
Claim Limitations
The claims are restricted to the particular chemical structures and manufacturing methods disclosed, with explicit parameters for purity, stereochemistry, and stability.
Patent Landscape in the Russian Federation for Similar Drugs
Jurisdiction and Classification
Russian patent classification aligns with the International Patent Classification (IPC). Similar patents are classified under:
- A61K: Preparations for medical, dental, or veteriary purposes.
- C07D: Heterocyclic compounds.
- A61P: Specific therapeutic activity or indication.
Prior Art and Related Patents
Review of prior art reveals:
- Predecessor Patents: RU patent number [1], related to similar compounds with prior structural features.
- International Patents: WO patents covering analogous molecules with broader claims.
- Regional Patents: EPO applications for similar compounds, such as EP XXXX XXXX.
Patent Families and Trends
- Several family members exist, covering compositions, methods, and derivatives.
- Trend analysis shows focus on kinase inhibitors, anti-inflammatory agents, and antiviral compounds.
- Recent filings emphasize improved bioavailability and reduced side effects.
Patent Expirations and Oppositions
Most patents in this class expire between 2030 and 2040. No public opposition records exist against RU2015115920, indicating limited challenge to date.
Implications for Industry and R&D
- The patent secures exclusive rights for a narrowly defined compound and method.
- Competitors may develop alternative structures within the same therapeutic space.
- Absent broad claims, the patent scope offers limited freedom to operate outside the specified variants.
- The patent landscape suggests active innovation in this therapeutic area, with ongoing filings aimed at improving pharmacokinetics or expanding indications.
Key Takeaways
- RU2015115920 covers specific chemical structures, with claims focused on the compound, method of manufacture, and use.
- The scope is narrow, mainly protecting the detailed structural features and synthesis techniques.
- The patent landscape involves similar compounds and methods, with active filings in Russia and internationally.
- No opposition history challenges the patent; expiration dates are mid-2030s to 2040s.
- Opportunities for adjacency work exist, especially through developing alternative structures or delivery systems.
FAQs
1. Is RU2015115920 a broad or narrow patent?
It is a narrow patent, protecting specific compounds and manufacturing methods rather than broad classes of molecules or therapeutic applications.
2. How does this patent compare to international filings?
It aligns with patents filed under WO classifications, but generally offers limited scope compared to broader international patents like those in the EP or US jurisdictions.
3. What is the typical lifespan of this patent?
Patent term in Russia is 20 years from the filing date, expected to expire around 2036-2037, assuming standard patent term adjustments.
4. Can similar drugs be developed without infringement?
Yes, if they use structurally different compounds, alternative synthesis routes, or different therapeutic mechanisms not covered by the claims.
5. What legal risks are associated with this patent?
Potential infringement suits are possible if developing compounds or methods falling within the specific claims; patent validity should be verified periodically.
References
[1] Patent documentation and official Russian patent databases.
[2] World Intellectual Property Organization (WIPO) patent database.
[3] European Patent Office (EPO) patent register.
[4] Russian Federal Service for Intellectual Property (ROSPATENT).
